This Viewpoint explores whether ctDNA will have the same far-reaching implications for the future of solid tumor oncology that prostate-specific antigen has had for prostate cancer.
JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.
This randomized clinical trial of women with hormone receptor-positive recurrent or metastatic endometrial cancer examines adverse events and cancer recurrence among patients treated with vistusertib plus anastrozole and compares them with patients treated with anastrozole alone.
RMEI LIGHTNING TALKS
View Details
4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far
RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
Allergy & Immunology
2021
View Details
Effectiveness of 5-year IBD Provider Online Educational Intervention Program
There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
Latest Hematology / Oncology Articles
